Neuroprotective effect of piperine on primarily cultured hippocampal neurons

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 4, 2010, Pages 598-603

  Fu, Min ^a   Sun, Zhao Hui ^a   Zuo, Huan Cong ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Calcium oscillation; Glutamateinduced excitotoxicity; Hippocampal neuron; Piperine; Spontaneous excitatory postsynaptic current; Spontaneous synaptic current

Indexed keywords

CALCIUM ION; GLUTAMIC ACID; PIPERINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HIPPOCAMPUS; NERVE CELL; NERVE CELL NECROSIS; NERVE CELL NETWORK; NEUROPROTECTION; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC NERVE; PROTEIN SECRETION; RAT; SYNAPSE;

ALKALOIDS; ANIMALS; ANTICONVULSANTS; APOPTOSIS; BENZODIOXOLES; CALCIUM; CALCIUM SIGNALING; CELL SURVIVAL; DRUGS, CHINESE HERBAL; EPILEPSY; GLUTAMIC ACID; HIPPOCAMPUS; NEURONS; NEUROPROTECTIVE AGENTS; PIPER NIGRUM; PIPERIDINES; POLYUNSATURATED ALKAMIDES; RATS; SIGNAL TRANSDUCTION; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 77950868992     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.598     Document Type: Article

References (48)

1. Selvendiran K., Singh J. P., Krishnan K. B., Sakthisekaran D., Fitotherapia, 74, 109-115 (2003).
2. Rauscher F. M., Sanders R. A., Watkins J. B. 3rd, J. Biochem. Mol. Toxicol., 14, 329-334 (2000).
3. Sunila E. S., Kuttan G., J. Ethnopharmacol., 90, 339-346 (2004).
4. Bhardwaj R. K., Glaeser H., Becquemont L., Klotz U., Gupta S. K., Fromm M. F., J. Pharmacol. Exp. Ther., 302, 645-650 (2002).
5. Wattanathorn J., Chonpathompikunlert P., Muchimapura S., Priprem A., Tankamnerdthai O., Food Chem. Toxicol., 46, 3106-3110 (2008).
6. Li S., Wang C., Li W., Koike K., Nikaido T., Wang M. W., J. Asian Nat. Prod. Res., 9, 421-430 (2007).
7. Li S., Wang C., Wang M., Li W., Matsumoto K., Tang Y., Life Sci., 80, 1373-1381 (2007).
8. D'Hooge R., Pei Y. Q., Raes A., Lebrun P., van Bogaert P. P., de Deyn P. P., Arzneim-Forsch., 46, 557-560 (1996).
9. Kashiwadani H., Sasaki Y. F., Uchida N., Mori K., J. Neurophysiol., 82, 1786-1792 (1999).
10. Buzsaki G., Draguhn A., Science, 304, 1926-1929 (2004).
11. Shatz C. J., Neuron, 5, 745-756 (1990).
12. Komuro H., Rakic P., Neuron, 17, 275-285 (1996).
13. Salinas E., Sejnowski T. J., Nat. Rev. Neurosci., 2, 539-550 (2001).
14. Singer W., Gray C. M., Annu. Rev. Neurosci., 18, 555-586 (1995).
15. Tallon-Baudry C., Bertrand O., Trends Cogn. Sci., 3, 151-162 (1999).
16. Gross J., Schmitz F., Schnitzler I., Kessler K., Shapiro K., Hommel B., Schnitzler A., Proc. Natl. Acad. Sci. U.S.A., 101, 13050-13055 (2004).
17. Traub R. D., Epilepsy Curr., 3, 77-79 (2003).
18. van der Stelt O., Belger A., Lieberman J. A., Proc. Natl. Acad. Sci. U.S.A., 101, 17567-17568 (2004).
19. Jeong J., Clin. Neurophysiol., 115, 1490-1505 (2004).
20. Hutchison W. D., Dostrovsky J. O., Walters J. R., Courtemanche R., Boraud T., Goldberg J., Brown P., J. Neurosci., 24, 9240-9243 (2004).
21. Scharfman H. E., Curr. Neurol. Neurosci. Rep., 7, 348-354 (2007).
22. Shi L. H., Luo F., Woodward D. J., Mclntyre D. C., Chang J. Y., Epilepsy Res., 73, 85-97 (2007).
23. Wallenstein G. V., Hasselmo M. E., Brain Res. Bull., 43, 485-493 (1997).
24. Bacci A., Verderio C., Pravettoni E., Matteoli M., Eur. J. Neurosci., 11, 389-397 (1999).
25. Arimura N., Kaibuchi K., Nat. Rev. Neurosci., 8, 194-205 (2007).
26. Matteoli M., Verderio C., Krawzeski K., Mundigl O., Coco S., Fumagalli G., De Camilli P., J. Physiol. (Paris), 89, 51-55 (1995).
27. Liu Z., Geng L., Li R., He X. Zheng J. Q., Xie Z., J. Neurosci., 23, 4156-4163 (2003).
28. Chen X., Liu J., Gu X., Ding F., Brain Res., 1238, 189-198 (2008).
29. Pei Y. Q., Epilepsia, 24, 177-182 (1983).
30. Wang S. M., Dou G. F., Li Q., Liu T., Meng Z. Y., Lou Y. Q., Zhang G. L., J. Chromatogr. B, 850, 92-100 (2006).
31. Hou T. J., Wang J. M., Liao N., Xu X. J., J. Chem. Inf. Comput. Sci., 39, 775-781 (1999).
32. Rogawski M. A., Loscher W., Nat. Rev. Neurosci., 5, 553-564 (2004).
33. Herman S. T., Epilepsy Res., 68, 35-38 (2006).
34. Aroniadou-Anderjaska V., Fritsch B., Qashu F., Braga M. F., Epilepsy Res., 78, 102-116 (2008).
35. Henshall D. C., Biochem. Soc. Trans., 35, 421-423 (2007).
36. Meldrum B. S., Prog. Brain Res., 135, 487-495 (2002).
37. Unchern S., Saito H., Nishiyama N., Biol. Pharm. Bull., 20, 958-961 (1997).
38. Henshall D. C., Araki T., Schindler C. K., Lan J. Q., Tiekoter K. L., Taki W., Simon R. P., J. Neurosci., 22, 8458-8465 (2002).
39. Shinoda S., Schindler C. K., Meller R., So N. K., Araki T., Yamamoto A., Lan J. Q., Taki W., Simon R. P. Henshall D. C., J. Clin. Invest., 113, 1059-1068 (2004).
40. Shinoda S., Skradski S. L., Araki T., Schindler C. K., Meller R., Lan J. Q., Taki W., Simon R. P., Henshall D. C., Eur. J. Neurosci., 17, 2065-2076 (2003).
41. Szallasi A., Trends Pharmacol. Sci., 26, 437-439 (2005).
42. Cristino L., de Petrocellis L., Pryce G., Baker D., Guglielmotti V., Di Marzo V., Neuroscience, 139, 1405-1415 (2006).
43. Toth A., Boczan J., Kedei N., Lizanecz E., Bagi Z., Papp Z., Edes I., Csiba, L., Blumberg, P. M., Brain Res. Mol. Brain Res., 135, 162-168 (2005).
44. Gibson H. E., Edwards J. G., Page R. S., Van Hook M. J., Kauer J. A., Neuron, 57, 746-59 (2008).
45. Mann E. O., Paulsen O., Trends Neurosci., 30, 343-159 (2007).
46. Hablitz J. J., Epilepsy Curr., 4, 151-153 (2004).
47. Liu M., Liu M. C., Magoulas C., Priestley J. V., Willmott N. J., J. Biol. Chem., 278, 5462-5472 (2003).
48. Khajuria A., Zutshi U., Bedi K. L., Ind. J. Exp. Biol., 36, 46-50 (1998).